Common Contracts
4 similar Underwriting Agreement contracts by Biota Pharmaceuticals, Inc., Cypress Sharpridge Investments, Inc., CYS Investments, Inc., Nordic American Tanker Shipping LTD
Common Stock BIOTA PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 10th, 2014 • Biota Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Biota Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriter named in Schedule I hereto (the “Underwriter”) an aggregate of 5,813,900 shares (the “Firm Shares”) of its common stock, par value $0.10 per share (the “Common Stock”). The Company also proposes to issue and sell to the Underwriter up to an additional 872,085 shares (the “Additional Shares”) of Common Stock at the option of the Underwriter as provided in Section 2(c) below. The Firm Shares and any Additional Shares purchased by the Underwriter are referred to herein as the “Shares”. Guggenheim Securities, LLC (“Guggenheim”) is acting as representative (the “Representative”) of the Underwriter in connection with the offering and sale of the Shares contemplated herein (the “Offering”).
25,000,000 Shares of Common Stock CYS INVESTMENTS, INC. UNDERWRITING AGREEMENT January 27, 2012Underwriting Agreement • January 30th, 2012 • CYS Investments, Inc. • Real estate investment trusts • New York
CYS Investments, Inc., a corporation organized and existing under the laws of Maryland (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 25,000,000 shares (the “Firm Shares”) of its Common Stock, par value $0.01 per share (the “Common Stock”). At the option of the Underwriters, the Company also proposes to issue and sell to the Underwriters up to an additional 3,750,000 shares of Common Stock (the “Additional Shares” and together with the Firm Shares, the “Shares”). Credit Suisse Securities (USA) LLC, Barclays Capital Inc., Deutsche Bank Securities Inc., UBS Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as the joint bookrunners in connection with the offering and sale of the Shares contemplated herein (the “Offering”).
3,000,000 Shares of Common Stock NORDIC AMERICAN TANKER SHIPPING LIMITED UNDERWRITING AGREEMENT January 8, 2009Underwriting Agreement • January 12th, 2009 • Nordic American Tanker Shipping LTD • Water transportation • New York
Nordic American Tanker Shipping Limited, a company organized and existing under the laws of the Islands of Bermuda (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Morgan Stanley & Co. Incorporated (the “Underwriter”) an aggregate of 3,000,000 shares (the “Firm Shares”) of its common shares, par value $0.01 per share (the “Common Stock”) and, for the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriter, up to an additional 450,000 shares (the “Additional Shares”) of Common Stock. The Firm Shares and any Additional Shares purchased by the Underwriter are referred to herein as the “Shares”.
18,000,000 Shares of Common Stock CYPRESS SHARPRIDGE INVESTMENTS, INC. UNDERWRITING AGREEMENT October , 2007Underwriting Agreement • October 16th, 2007 • Cypress Sharpridge Investments, Inc. • Real estate investment trusts • New York
Cypress Sharpridge Investments, Inc., a corporation organized and existing under the laws of Maryland (the “Company”), which is externally managed and advised by Cypress Sharpridge Advisors LLC, a limited liability company organized and existing under the laws of Delaware (the “Manager”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 18,000,000 shares (the “Firm Shares”) of its Common Stock, par value $0.01 per share (the “Common Stock”). For the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters, the Company also proposes to issue and sell to the Underwriters up to an additional 2,700,000 shares of Common Stock (the “Additional Shares” and together with the Firm Shares, the “Shares”). Bear, Stearns & Co. Inc., Friedman, Billings, Ramsey & Co., Inc. and UBS Securities LLC are acting as lead m
